These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 23544170)

  • 1. Down-regulation of miR-21 Induces Differentiation of Chemoresistant Colon Cancer Cells and Enhances Susceptibility to Therapeutic Regimens.
    Yu Y; Sarkar FH; Majumdar AP
    Transl Oncol; 2013 Apr; 6(2):180-6. PubMed ID: 23544170
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Omega-3 fatty acid is a potential preventive agent for recurrent colon cancer.
    Vasudevan A; Yu Y; Banerjee S; Woods J; Farhana L; Rajendra SG; Patel A; Dyson G; Levi E; Maddipati KR; Majumdar AP; Nangia-Makker P
    Cancer Prev Res (Phila); 2014 Nov; 7(11):1138-48. PubMed ID: 25193342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miR-21 and miR-145 cooperation in regulation of colon cancer stem cells.
    Yu Y; Nangia-Makker P; Farhana L; G Rajendra S; Levi E; Majumdar AP
    Mol Cancer; 2015 May; 14():98. PubMed ID: 25928322
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metformin: a potential therapeutic agent for recurrent colon cancer.
    Nangia-Makker P; Yu Y; Vasudevan A; Farhana L; Rajendra SG; Levi E; Majumdar AP
    PLoS One; 2014; 9(1):e84369. PubMed ID: 24465408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Difluorinated-curcumin (CDF) restores PTEN expression in colon cancer cells by down-regulating miR-21.
    Roy S; Yu Y; Padhye SB; Sarkar FH; Majumdar AP
    PLoS One; 2013; 8(7):e68543. PubMed ID: 23894315
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Difluorinated-curcumin (CDF): a novel curcumin analog is a potent inhibitor of colon cancer stem-like cells.
    Kanwar SS; Yu Y; Nautiyal J; Patel BB; Padhye S; Sarkar FH; Majumdar AP
    Pharm Res; 2011 Apr; 28(4):827-38. PubMed ID: 21161336
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination of dasatinib and curcumin eliminates chemo-resistant colon cancer cells.
    Nautiyal J; Kanwar SS; Yu Y; Majumdar AP
    J Mol Signal; 2011 Jul; 6():7. PubMed ID: 21774804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of miR-34 is lost in colon cancer which can be re-expressed by a novel agent CDF.
    Roy S; Levi E; Majumdar AP; Sarkar FH
    J Hematol Oncol; 2012 Sep; 5():58. PubMed ID: 22992310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-21 induces stemness by downregulating transforming growth factor beta receptor 2 (TGFβR2) in colon cancer cells.
    Yu Y; Kanwar SS; Patel BB; Oh PS; Nautiyal J; Sarkar FH; Majumdar AP
    Carcinogenesis; 2012 Jan; 33(1):68-76. PubMed ID: 22072622
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elimination of Colon Cancer Stem-Like Cells by the Combination of Curcumin and FOLFOX.
    Yu Y; Kanwar SS; Patel BB; Nautiyal J; Sarkar FH; Majumdar AP
    Transl Oncol; 2009 Dec; 2(4):321-8. PubMed ID: 19956394
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Schlafen-3 decreases cancer stem cell marker expression and autocrine/juxtacrine signaling in FOLFOX-resistant colon cancer cells.
    Oh PS; Patel VB; Sanders MA; Kanwar SS; Yu Y; Nautiyal J; Patel BB; Majumdar AP
    Am J Physiol Gastrointest Liver Physiol; 2011 Aug; 301(2):G347-55. PubMed ID: 21596996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liposome encapsulated curcumin-difluorinated (CDF) inhibits the growth of cisplatin resistant head and neck cancer stem cells.
    Basak SK; Zinabadi A; Wu AW; Venkatesan N; Duarte VM; Kang JJ; Dalgard CL; Srivastava M; Sarkar FH; Wang MB; Srivatsan ES
    Oncotarget; 2015 Jul; 6(21):18504-17. PubMed ID: 26098778
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bile acid: a potential inducer of colon cancer stem cells.
    Farhana L; Nangia-Makker P; Arbit E; Shango K; Sarkar S; Mahmud H; Hadden T; Yu Y; Majumdar AP
    Stem Cell Res Ther; 2016 Dec; 7(1):181. PubMed ID: 27908290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gercumin synergizes the action of 5-fluorouracil and oxaliplatin against chemoresistant human cancer colon cells.
    Genovese S; Epifano F; Preziuso F; Slater J; Nangia-Makker P; Majumdar APN; Fiorito S
    Biochem Biophys Res Commun; 2020 Jan; 522(1):95-99. PubMed ID: 31740005
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modified TLR-mediated downregulation of miR-125b-5p enhances CD248 (endosialin)-induced metastasis and drug resistance in colorectal cancer cells.
    Park GB; Jeong JY; Kim D
    Mol Carcinog; 2020 Feb; 59(2):154-167. PubMed ID: 31746054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metformin Enhancement of Therapeutic Effects of 5-Fluorouracil and Oxaliplatin in Colon Cancer Cells and Nude Mice.
    Yip KL; Tsai TN; Yang IP; Miao ZF; Chen YC; Li CC; Su WC; Chang TK; Huang CW; Tsai HL; Yeh YS; Wang JY
    Biomedicines; 2022 Apr; 10(5):. PubMed ID: 35625692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Maintenance of the stemness in CD44(+) HCT-15 and HCT-116 human colon cancer cells requires miR-203 suppression.
    Ju SY; Chiou SH; Su Y
    Stem Cell Res; 2014 Jan; 12(1):86-100. PubMed ID: 24145190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypoxia-induced aggressiveness of pancreatic cancer cells is due to increased expression of VEGF, IL-6 and miR-21, which can be attenuated by CDF treatment.
    Bao B; Ali S; Ahmad A; Azmi AS; Li Y; Banerjee S; Kong D; Sethi S; Aboukameel A; Padhye SB; Sarkar FH
    PLoS One; 2012; 7(12):e50165. PubMed ID: 23272057
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Omega-3 eicosapentaenoic acid decreases CD133 colon cancer stem-like cell marker expression while increasing sensitivity to chemotherapy.
    De Carlo F; Witte TR; Hardman WE; Claudio PP
    PLoS One; 2013; 8(7):e69760. PubMed ID: 23874993
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Curcumin targets FOLFOX-surviving colon cancer cells via inhibition of EGFRs and IGF-1R.
    Patel BB; Gupta D; Elliott AA; Sengupta V; Yu Y; Majumdar AP
    Anticancer Res; 2010 Feb; 30(2):319-25. PubMed ID: 20332435
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.